Best Apps for the GLP-1 Maintenance Phase: Avoid the Rebound

The hardest part of GLP-1 weight loss is not the loss itself. It is the maintenance phase that follows, where most patients fail. Trial data is consistent: roughly two-thirds of patients regain most of their lost weight within a year of stopping the medication.

The minority who maintain do something different. They built habits during loss. They tapered slowly instead of stopping cold. They often stayed on a low maintenance dose long-term. The right app supports all three.

This guide covers what to look for and the focused tool we recommend.

What maintenance actually requires

Five inputs:

1. Continued protein floor. The same 0.7 to 1.0 g per pound of goal weight that protected muscle during loss continues to matter during maintenance.

2. Continued resistance training. Stop lifting and you start losing the muscle you protected during loss. Maintain the schedule.

3. A real plan for the off-ramp. If you are tapering the medication, the steps matter. Drop one dose level every 8 to 12 weeks, not all at once. See our taper guide.

4. Weekly weigh-in instead of daily. During maintenance, the trend matters more than ever. A 2 to 4 pound bump that resolves in a week is normal. A 5+ pound trend that does not resolve is signal.

5. Quick re-initiation if drift begins. Starting a low maintenance dose at the first sign of consistent regain is much easier than letting 15 pounds come back before acting.

The recommended app: Sharpy

Sharpy is one of the few apps that explicitly supports maintenance. The app shifts mode automatically when you transition out of active loss:

• Lower deficit pressure. The protein floor stays. The lifting program stays. The calorie pressure relaxes.
• Weekly weigh-in. Daily noise is filtered out. Weekly trend is the signal.
• Off-ramp content. If you are tapering the medication, the Learn Hub surfaces the relevant articles, dose timing, and what to expect at each step down.
• Drift alerts. When your weekly trend exceeds typical fluctuation, the app surfaces it as a flag, not a panic.
• Habit consistency tracking. The Shape Score continues. Maintenance is a continuation of the habits that worked during loss.

Get Sharpy on the App Store. Free to download.

A realistic maintenance routine

The pattern that holds the loss long-term:

• 5 protein meals or snacks per day, anchor times
• 3 lifting sessions per week, progressive overload continuing
• 7,000+ steps daily, walks after meals
• Weekly weigh-in, same day, same time, same conditions
• Monthly waist circumference and progress photos
• Quarterly check-in with your prescriber about dose maintenance

Sharpy tracks all of these. The maintenance phase looks similar to the loss phase, just with the calorie pressure relaxed.

The off-ramp specifically

If you are deciding to taper rather than stay on long-term, Sharpy supports the structured taper:

• Phase 1 (months 1 to 2): Drop one dose level, maintain habits, monitor weight.
• Phase 2 (months 3 to 4): Drop another dose level, expect appetite to start returning.
• Phase 3 (months 5 to 6): Lowest maintenance dose, decide whether to stay or fully stop.
• Phase 4 (months 7+): Off entirely, with clear re-initiation criteria if drift begins.

The app surfaces the relevant content at each phase and tracks weight against your stable maintenance baseline.

What other apps miss

Most weight loss apps end at goal weight. The dashboard celebrates "you hit your goal!" and then stops being useful. For GLP-1 patients, that is the wrong moment to disengage. The harder problem is just starting.

Sharpy is one of the few apps that treats maintenance as a real, ongoing phase with its own structure.

When to restart the medication

If you fully stopped and are seeing drift, restarting at a low dose is medically reasonable. Triggers to discuss with your prescriber:

• Sustained 5+ pound regain over 4+ weeks
• Cravings and food noise returning aggressively
• Loss of habits despite intention
• Metabolic markers (HbA1c, lipids) trending the wrong way

There is no shame in restarting. The framing of "I should be able to do this without the medication" is a relic of the willpower model. GLP-1 is increasingly considered a chronic medication, like blood pressure medication, for many patients. See our research summary.

Bottom line

Maintenance is harder than loss for most GLP-1 patients. The right app extends past the loss period, supports the off-ramp, weighs the trend not the day, and surfaces drift early. Sharpy is the focused tool with explicit maintenance mode. Download it from the App Store. Free.